Pluribus Labs’s Baxter International BAX Stock Holding History

Pluribus Labs’s Portfolio BAX Stock Details BAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,840	Closed	-$244K	–	68
2021 Q4	$244K	Buy	+2,840	New	+$229K	0.26%	175

Other funds holding BAX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Pluribus Labs's BAX Position: Q1 2022 in Review

Pluribus Labs sold out of Baxter International (BAX) in Q1 2022, closing a stake of 2,840 shares — an estimated $244K sold.

Pluribus Labs first reported a position in BAX in Q4 2021 and held it in 1 quarter. The position peaked at $244K in Q4 2021. 1,146 funds tracked by Wall St. Rank hold BAX as of Q1 2022.

Pluribus Labs reported no remaining Baxter International position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 2,840 Baxter International shares in Q1 2022, an estimated $244K.
Pluribus Labs first reported a position in Baxter International in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Baxter International position peaked at $244K in Q4 2021.
1,146 funds tracked by Wall St. Rank held Baxter International as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.